Library
ASHA Improving Health and Nutrition of Indian Women with AIDS and Their Children
Needle exchange programs (NEP)
More than a million people in the US inject drugs frequently, at a cost to society in health care, lost productivity, accidents, and crime of more than $50 billion a year. People who inject drugs imperil their own health. If they contract HIV or hepatitis, their needle-sharing partners, sexual partners and offspring may become infected. It is estimated that half of all new HIV infections in the US are occurring among injection drug users (IDUs). For women, 61% of all AIDS cases are due to injection drug use or sex with partners who inject drugs. Injection drug use is the source of infection for more than half of all children born with HIV. Injection drug use is also the most common risk factor in persons with hepatitis C infection. Up to 90% of IDUs are estimated to be infected with hepatitis C, which is easily transmitted and can cause chronic liver disease. Hepatitis B is also transmitted via injection drug use. Needle exchange programs (NEPs) distribute clean needles and safely dispose of used ones for IDUs, and also generally offer a variety of related services, including referrals to drug treatment and HIV counseling and testing.
Mother-to-child transmission (MTCT)
International HIV Prevention Research at the Center for AIDS Prevention Studies, University of California San Francisco
Transgender Evaluation and Technical Assistance Center (TETAC)
- Goal 1 (Evaluation) To provide support to the demonstration sites as they design and implement their site-specific evaluation plans, and to conduct rigorous, cross-site evaluation research that will make a significant contribution to improving the timely entry, engagement, and retention (from the cascade of care model) in quality HIV primary care for transwomen of color.
- Goal 2 (TA) To provide TA tailored to the specific needs of each demonstration site through teleconferences, a website, webinars, site visits, and meetings in a variety of domains including (1) program development, implementation, and sustainability; (2) clinical consultation; (3) multi-site and location evaluation; (4) human research protection; (5) IRBs; and (6) intervention manuals.
- Goal 3 (Capacity Building) To provide capacity building assistance (CBA) relating to the provision of quality clinical and culturally competent HIV primary care and social services to transwomen of color.
- Goal 4 (Dissemination) To synthesize and disseminate findings from demonstration projects to optimize impact on the timely entry, engagement, and retention in quality HIV primary care for transwomen of color.